Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Tolerability of Influsplit SSW 2005/2006 in Children
NCT00372255Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Primary completion
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluarix in influenza, sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00372255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372255.